AZ ‘consulted first’ by UK government after Pfizer bid
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, George Osborne, Pfizer, Wellcome Trust, david cameron
UK prime minister David Cameron has rejected claims that his government is prioritising discussions with Pfizer over its proposed acquisition …
Pfizer signs universities deal
May 12, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, academics, rare diseases
Pfizer has signed a five-year research deal with several top British universities to hunt for new treatments for rare disease. …
‘Bioscience is cornerstone’ of Alderley Park
May 12, 2014Research and Development, Sales and Marketing AZ, AstraZeneca, alderley, msp, research
Manchester Science Parks (MSP), the new owners of the 400-acre Alderley Park facility, has pledged to keep its activities “at …
Lundbeck buys Chelsea Therapeutics
May 12, 2014Research and Development, Sales and Marketing Chelsea Therapeutics, Lundbeck
Lundbeck could pay as much as $658 million for neurological disorder specialist Chelsea Therapeutics as the firm looks to shore …
Clinical trials transparency: the journey so far
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency
There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …
Talentmark hires Benelux executive search head
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Talentmark, lebbink
Life sciences recruitment firm Talentmark has confirmed Christiaan Lebbink is to join the firm covering the Benelux and continental European region Lebbink, …
Merck’s vorapaxar gains long-awaited FDA approval
May 9, 2014Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity
Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …
AstraZeneca begins lung cancer trial
May 9, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, MEDI4736, NSCLC, lung cancer
AstraZeneca, currently at the centre of a £63 billion bid from US giant Pfizer, has begun a late-stage trial of …
Wellcome Trust slams Pfizer/AstraZeneca bid
May 9, 2014Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover
The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …
Latest Sun Pharma recall blow for firm
May 9, 2014Manufacturing and Production Caraco, Cetirizine, Effexor, FDA, Sun Pharma, recall
India’s largest drugmaker Sun Pharmaceutical Industries is recalling almost 400,000 bottles of anti-depressant and antihistamine medications in the US, because …
ABPI appoints manager 
from Pfizer

May 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pfizer, christine rowland
The ABPI has appointed Christine Rowland to the newly-created position of value and access manager for its commercial department. Rowland …
NICE recommends Xtandi
May 9, 2014Sales and Marketing Astellas, NICE, Xtandi, abiraterone, prostate
NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …
EU looks at eye drug allegations
May 8, 2014Sales and Marketing EU, Lucentis, Novartis, Roche, avastin, offlabel
European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …
3D printed hearts ‘on the horizon’
May 8, 2014Medical Communications, Sales and Marketing 3D, heart, louisville, printing, williams
The ‘inherent design flaws’ of the human heart could become a thing of the past as new 3D printing technology …
Cobra Biologics appoints CSO

May 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, cobra biologics, smith
Contract manufacturing organisation Cobra Biologics has hired Dr Daniel Smith as its chief scientific officer. Smith has spent the last …
RPS: ‘Give pharma incentives’
May 8, 2014Research and Development, Sales and Marketing NHS, RPS, rare diseases, royal pharmaceutical society
Incentives are urgently required to speed up the development of personalised medicines, according to a new report from the Royal …
ICON appoints non-executive director
May 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, brady
Contract research organisation (CRO) ICON has appointed Dr Hugh Brady as a non-executive director. Brady previously served as president at …
Global cancer drug spend slows
May 7, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, IMS, spending
Spending on cancer drugs worldwide is slowing, according to a new report from the IMS Institute for Healthcare Informatics. The …
Bayer concludes $14bn Merck consumer care takeover
May 7, 2014Sales and Marketing Bayer, Merck, OTC, consumer care, merger
Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …
US cancer docs warn of rising drug prices
May 7, 2014Research and Development, Sales and Marketing ASCO, Cancer, NICE, Obama, US, United States, republicans
American cancer doctors are warning that the rising price of oncology medicines is making it unaffordable for the country’s healthcare …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
